Drug Shortage Report for CORTENEMA
| Report ID | 105626 |
| Drug Identification Number | 02112736 |
| Brand name | CORTENEMA |
| Common or Proper name | hydrocortisone |
| Company Name | APTALIS PHARMA CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HYDROCORTISONE |
| Strength(s) | 100MG |
| Dosage form(s) | ENEMA |
| Route of administration | RECTAL |
| Packaging size | 100mg |
| ATC code | A07EA |
| ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2020-02-10 |
| Actual start date | 2020-02-10 |
| Estimated end date | 2020-03-03 |
| Actual end date | 2020-03-05 |
| Shortage status | Resolved |
| Updated date | 2020-03-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-03-06 | English | Compare |
| v5 | 2020-03-05 | French | Compare |
| v4 | 2020-03-05 | English | Compare |
| v3 | 2020-02-11 | English | Compare |
| v2 | 2020-02-10 | French | Compare |
| v1 | 2020-02-10 | English | Compare |
Showing 1 to 6 of 6